NCT02185963View on ClinicalTrials.gov

Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2016

Conditions
Diabetes
Interventions
DRUG

Rosuvastatin

Rosuvastatin 20mg once a daily for 12 weeks

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT02185963 - Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 Diabetes | Biotech Hunter | Biotech Hunter